 | TAK-779 cation | IC50 | 12.0 [1] |
 | CID 10436045 | Ki | 50.0 [1], 50.12 [2] |
 | Teijin-lead_cmp_5 | IC50 | 16.0 [1], 54.0 [2], 70.0 [3], 300.0 [4] |
 | 6-Methyl-1'-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]spiro[1H-3,1-benzoxazine-4,4'-piperidine]-2-one | IC50 | 89.0 [1] |
 | Bms ccr2 22 | IC50 | 1.0 [1], 18.0 [2] |
 | 2-Amino-N-[2-[[4-[(4-methylsulfanylbenzoyl)amino]piperidin-3-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 75.0 [1], 109.0 [2] |
 | [(1S,3R)-3-[[(3S,4S)-3-Methoxyoxan-4-yl]amino]-1-propan-2-ylcyclopentyl]-[4-[4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]methanone | IC50 | 3.2 [1] |
 | CCR2 antagonist 4 | IC50 | 24.0 [1], 180.0 [2], 300.0 [3], 980.0 [4] |
 | Incb8761(PF-4136309) | IC50 | 0.5 [1], 3.3 [2], 3.9 [3], 5.2 [4], 19.0 [5] |
 | (E)-3-(3,4-Dichlorophenyl)-N-[4-[[4-(5-hydroxy-1H-indol-3-yl)piperidin-1-yl]methyl]cyclohexyl]prop-2-enamide | Ki | 79.43 [1], 126.0 [2], 316.0 [3], 316.23 [4] |
 | N-[2-[[(1S,2R,4R)-2-(Benzenesulfonylmethyl)-4-[methyl(propan-2-yl)amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 0.8 [1], 1.3 [2] |
 | [(1S,3R)-3-[[(3S,4S)-3-Methoxyoxan-4-yl]amino]-1-propan-2-ylcyclopentyl]-[4-[4-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl]methanone | IC50 | 8.5 [1], 8.9 [2], 11.0 [3], 17.0 [4], 18.2 [5] |
 | [(1S,3R)-3-[[(3S,4S)-3-Methoxyoxan-4-yl]amino]-1-propan-2-ylcyclopentyl]-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]methanone | IC50 | 6.2 [1], 18.8 [2], 27.5 [3], 79.0 [4] |
 | 2-Amino-N-[2-[[4-[(4-methylsulfanylphenyl)methylamino]piperidin-3-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 6.1 [1], 6.3 [2], 7.0 [3], 285.0 [4], 749.3 [5] |
 | 2-[1-[(E)-3-(3,5-Difluorophenyl)prop-2-enoyl]piperidin-4-yl]-2-[[4-(1H-indol-3-yl)cyclohexyl]amino]acetamide | IC50 | 4.0 [1], 6.0 [2], 187.0 [3], 740.0 [4] |
 | (S)-N-(3,5-Bis(trifluoromethyl)benzyl)-2-(4-fluorophenyl)-2-(2-(piperidin-1-yl)ethylamino)acetamide | IC50 | 173.78 [1], 175.0 [2], 180.0 [3] |
 | (2S)-N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-2-[2-(dimethylamino)ethylamino]-2-(4-fluorophenyl)acetamide | IC50 | 720.0 [1], 770.0 [2], 776.25 [3] |
 | (E)-3-(3,4-Dichlorophenyl)-N-[4-[[4-(1H-indol-3-yl)piperidin-1-yl]methyl]cyclohexyl]prop-2-enamide | Ki | 125.89 [1], 126.0 [2], 631.0 [3], 645.65 [4] |
 | N-[2-[[(2S,3S)-1-[(2,4-Dimethylphenyl)methylamino]-3-hydroxyhexan-2-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 5.0 [1], 240.0 [2] |
 | N-[2-[[(2S,3S)-1-[(2,4-Dimethylphenyl)methylamino]-3-hydroxyhexan-2-yl]amino]-2-oxoethyl]-2-(propan-2-ylcarbamoylamino)-5-(trifluoromethyl)benzamide | IC50 | 4.7 [1], 9.9 [2] |
 | (2S)-N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-2-(2-piperidin-1-ylethylamino)-2-thiophen-3-ylacetamide | IC50 | 30.0 [1], 38.9 [2], 39.0 [3], 50.0 [4] |
 | (1S,3R)-N-[[3-Fluoro-5-(trifluoromethyl)phenyl]methyl]-3-[(1S,3'R)-3'-methylspiro[indene-1,4'-piperidine]-1'-yl]-1-propan-2-ylcyclopentane-1-carboxamide | IC50 | 0.15 [1], 0.71 [2], 3.09 [3], 3.1 [4] |
 | (1R,3R)-N-[[3-Fluoro-5-(trifluoromethyl)phenyl]methyl]-1-(2-methylpropyl)-3-[(1S,3'R)-3'-methylspiro[indene-1,4'-piperidine]-1'-yl]cyclopentane-1-carboxamide | IC50 | 0.32 [1], 2.04 [2], 3.89 [3], 3.9 [4] |
 | (1S,3R)-1-Cyclopropyl-N-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-3-[(1S,3'R)-3'-methylspiro[indene-1,4'-piperidine]-1'-yl]cyclopentane-1-carboxamide | IC50 | 0.23 [1], 0.63 [2], 1.9 [3], 1.91 [4] |
 | N-[(3S)-1-[(1S,2R,4R)-2-(Benzenesulfonylmethyl)-4-[methyl(propan-2-yl)amino]cyclohexyl]-2-oxopyrrolidin-3-yl]-3-(trifluoromethyl)benzamide | IC50 | 0.5 [1], 1.0 [2] |
 | 3,4-Dichloro-N-[5-chloro-2-(triazol-1-ylmethyl)phenyl]benzenesulfonamide | Ki | 10.0 [1], 79.43 [2], 100.0 [3] |
 | 2-Amino-N-[2-[[(3R)-1-[(4-chlorophenyl)methyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 3.6 [1], 23.1 [2], 26.0 [3], 45.0 [4] |
 | N-[2-[[2-[[(1S,3S,4R)-4-Amino-3-(benzenesulfonylmethyl)cyclohexyl]amino]-2-oxoethyl]carbamoyl]-4-(trifluoromethyl)phenyl]azetidine-1-carboxamide | IC50 | 1.4 [1], 6.6 [2], 8.0 [3], 10.0 [4] |
 | 2-[[4-(1H-Indol-3-yl)cyclohexyl]amino]-2-[1-[(E)-3-(3,4,5-trifluorophenyl)prop-2-enoyl]piperidin-4-yl]acetamide | IC50 | 16.0 [1], 25.0 [2], 406.0 [3], 880.0 [4] |
 | CID 57400418 | IC50 | 2.6 [1], 3.7 [2], 4.7 [3], 6.0 [4] |
 | (3S)-1-[(1S,2R,4R)-4-[Methyl(propan-2-yl)amino]-2-propylcyclohexyl]-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-2-one | IC50 | 0.24 [1], 0.7 [2], 4.7 [3] |
 | (2S)-N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-2-phenyl-2-(2-piperidin-1-ylethylamino)acetamide | IC50 | 218.78 [1], 219.0 [2], 220.0 [3] |
 | 2-[4-(1H-Indol-3-yl)piperidin-1-yl]-2-[1-[(E)-3-(3,4,5-trifluorophenyl)prop-2-enoyl]piperidin-4-yl]acetic acid | IC50 | 5.0 [1] |
 | 2-[4-(1H-Indol-3-yl)piperidin-1-yl]-2-[1-[(E)-3-(3,4,5-trifluorophenyl)prop-2-enoyl]piperidin-4-yl]acetamide | IC50 | 1800.0 [1] |
 | (2S)-N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-2-phenyl-2-[2-(4-phenylpiperidin-1-yl)ethylamino]acetamide | IC50 | 822.0 [1], 830.0 [2], 831.76 [3] |
 | (1S,3R)-N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-3-(2,3-dihydro-1H-inden-1-ylamino)-1-propan-2-ylcyclopentane-1-carboxamide | IC50 | 76.91 [1], 77.0 [2] |
| (1S,3R)-N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-3-(2,3-dihydro-1H-inden-1-ylamino)-1-propan-2-ylcyclopentane-1-carboxamide | Ki | 50.0 [1] |
 | [(1S,3R)-3-[[(3S,4S)-3-Methoxyoxan-4-yl]amino]-1-propan-2-ylcyclopentyl]-[4-[5-(trifluoromethyl)pyridazin-3-yl]piperazin-1-yl]methanone | IC50 | 7.7 [1], 8.1 [2], 25.7 [3] |
 | N-(3,4-Dichlorophenyl)-4-[(2R)-4-propan-2-ylpiperazine-2-carbonyl]piperazine-1-carboxamide | IC50 | 3.5 [1], 5.1 [2], 5.8 [3] |
 | N-[2-[[(2S,3S)-1-[(2,4-Dimethylphenyl)methylamino]-3-hydroxyhexan-2-yl]amino]-2-oxoethyl]-2-(ethylcarbamoylamino)-5-(trifluoromethyl)benzamide | IC50 | 3.6 [1], 24.0 [2] |
 | 3-[5-(3,5-Dichlorophenyl)-2-naphthalen-2-ylpyrazol-3-yl]oxy-N-[6-(diethylamino)-2-methylhexan-3-yl]propanamide | IC50 | 6.0 [1], 32.0 [2] |
 | 3-[5-(3,5-Dichlorophenyl)-2-naphthalen-2-ylpyrazol-3-yl]oxy-N-[1-(diethylamino)-6-methylheptan-4-yl]propanamide | IC50 | 73.96 [1], 74.0 [2], 178.0 [3] |
 | 4-[5-(3,5-Dichlorophenyl)-2-naphthalen-2-ylpyrazol-3-yl]-N-[5-(diethylamino)pentan-2-yl]butanamide | IC50 | 108.0 [1], 209.0 [2], 6471.43 [3] |
 | 3-[5-(3,5-Dichlorophenyl)-2-naphthalen-2-ylpyrazol-3-yl]oxy-N-[1-(diethylamino)heptan-4-yl]propanamide | IC50 | 43.95 [1], 44.0 [2], 154.0 [3] |
 | 3-[5-(3,5-Dichlorophenyl)-2-naphthalen-2-ylpyrazol-3-yl]oxy-N-[6-(diethylamino)hexan-3-yl]propanamide | IC50 | 8.99 [1], 9.0 [2], 83.0 [3] |
 | (E)-1-[4-[(1S)-2-Hydroxy-1-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl]piperidin-1-yl]-3-(3,4,5-trifluorophenyl)prop-2-en-1-one | IC50 | 2.4 [1], 3.5 [2], 2400.0 [3] |
 | 3-[5-(3,5-Dichlorophenyl)-2-naphthalen-2-ylpyrazol-3-yl]oxy-N-[5-(diethylamino)pentan-2-yl]propanamide | IC50 | 66.0 [1], 66.07 [2], 280.0 [3] |
 | 3-[[5-(3,5-Dichlorophenyl)-2-naphthalen-2-ylpyrazol-3-yl]amino]-N-[5-(diethylamino)pentan-2-yl]propanamide | IC50 | 29.99 [1], 30.0 [2], 54.0 [3] |
 | 1-Butyl-3-(2-methylpropyl)-9-(6-phenylhexyl)-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochloride | IC50 | 10000.0 [1] |
 | (2S)-2-(2-Acetamido-1,3-thiazol-4-yl)-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-4-(4-phenylpiperidin-1-yl)butanamide | IC50 | 0.7 [1], 1.8 [2], 1.82 [3] |
 | 3-[1-[5-(4-Biphenylylcarbonylamino)pentyl]-4-piperidinyl]-1H-indole | Ki | 5300.0 [1], 5400.0 [2], 5495.41 [3] |
 | (E)-3-(3,4-Dichlorophenyl)-N-[5-[(1R,5S)-3-(5-hydroxy-1H-indol-3-yl)-8-azabicyclo[3.2.1]octan-8-yl]pentyl]prop-2-enamide | Ki | 251.0 [1], 251.19 [2], 630.0 [3] |
 | (2S)-N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-2-cyclopropyl-4-[(1R,3'R)-3'-methylspiro[indene-1,4'-piperidine]-1'-yl]butanamide | IC50 | 4.0 [1], 14.0 [2] |
 | N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-2-cyclopropyl-4-spiro[indene-1,4'-piperidine]-1'-ylbutanamide | IC50 | 38.0 [1], 69.0 [2], 97.72 [3] |
 | N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-4-[(1R,3'R)-3'-methylspiro[indene-1,4'-piperidine]-1'-yl]butanamide | IC50 | 93.0 [1], 173.0 [2], 213.8 [3] |
 | (2S)-N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-2-[2-(methylcarbamoylamino)-1,3-thiazol-4-yl]-4-(4-phenylpiperidin-1-yl)butanamide | IC50 | 0.43 [1], 1.8 [2] |
 | (2R)-N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-2-[2-(methylcarbamoylamino)-1,3-thiazol-4-yl]-4-(4-phenylpiperidin-1-yl)butanamide | IC50 | 30.0 [1], 30.2 [2], 87.0 [3] |
 | Methyl (2S)-5-(diaminomethylideneamino)-2-[3-[5-(3,5-dichlorophenyl)-2-naphthalen-2-ylpyrazol-3-yl]oxypropanoylamino]pentanoate | IC50 | 61.94 [1], 62.0 [2], 118.0 [3] |
 | 3-[5-(3,5-Dichlorophenyl)-2-naphthalen-2-ylpyrazol-3-yl]oxy-N-[1-(diethylamino)-6-methyloctan-4-yl]propanamide | IC50 | 106.91 [1], 107.0 [2], 225.0 [3] |
 | N-[2-[[(3R)-1-[2-[4-(2-Chlorobenzoyl)piperazin-1-yl]ethyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 1.7 [1], 23.0 [2], 1120.0 [3] |
 | 3,4-Dichloro-N-[5-chloro-2-(2-methylpyridin-3-yl)oxypyridin-3-yl]benzenesulfonamide | Ki | 10.0 [1], 1259.0 [2] |
 | [(2R,3Ar,6aR)-2-[[(3R,4R)-3-methoxyoxan-4-yl]amino]-2,3,4,5,6,6a-hexahydro-1H-pentalen-3a-yl]-[3-(trifluoromethyl)-7,8-dihydro-5H-1,6-naphthyridin-6-yl]methanone | IC50 | 24.0 [1], 49.0 [2], 61.0 [3] |
 | 2-(Diethylcarbamoylamino)-N-[2-[[(1S,2R)-2-[(4-methylsulfanylphenyl)sulfonylmethyl]cyclohexyl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 6.5 [1], 34.0 [2], 39.5 [3] |
 | 2-Amino-N-[2-[[(2S)-1-(tert-butylamino)-3-[(2,4-dimethylphenyl)methylamino]-1-oxopropan-2-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 8.0 [1], 11.0 [2], 260.0 [3] |
 | N-[2-[[(1S,2R,4R)-4-Amino-2-[(4-methylsulfanylphenyl)sulfonylmethyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 7.5 [1], 13.1 [2], 21.0 [3] |
 | N-[2-[[(2S)-1-(Tert-butylamino)-3-[(2,4-dimethylphenyl)methylamino]-1-oxopropan-2-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 48.0 [1], 52.0 [2], 3000.0 [3] |
 | N-[2-[[(2S)-1-Amino-3-[(2,4-dimethylphenyl)methylamino]-1-oxopropan-2-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 66.0 [1], 69.0 [2], 1500.0 [3] |
 | N-[2-[[(2S)-1-(Tert-butylamino)-3-[(2,4-dimethylphenyl)methylamino]-1-oxopropan-2-yl]amino]-2-oxoethyl]-2-(ethylamino)-5-(trifluoromethyl)benzamide | IC50 | 13.0 [1], 84.0 [2], 100.0 [3] |
 | Rac-3-Isobutyl-9-(4-phenoxybenzyl)-1-propyl-1,4,9-triazaspiro[5.5]undecane-2,5-dione hydrochloride | IC50 | 30000.0 [1] |
 | N-[2-[[(1S,2R,4R)-2-[(4-Methylsulfanylphenyl)sulfonylmethyl]-4-(propan-2-ylamino)cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 2.05 [1], 5.1 [2], 10.4 [3] |
 | N-[2-[[(1S,2R,4R)-4-[Methyl(propan-2-yl)amino]-2-[(4-methylsulfanylphenyl)sulfonylmethyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 0.2 [1], 0.5 [2], 1.3 [3] |
 | N-[2-[[(1S,2R,4R)-4-(Dimethylamino)-2-[(4-methylsulfanylphenyl)sulfonylmethyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 0.3 [1], 0.37 [2], 2.5 [3] |
 | 2-(Dimethylcarbamoylamino)-N-[2-[[(1S,2R)-2-[(4-methylsulfanylphenyl)sulfonylmethyl]cyclohexyl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 8.1 [1], 21.0 [2], 43.5 [3] |
 | [(3S)-3-[[4-Hydroxy-4-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexyl]amino]pyrrolidin-1-yl]-[1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]methanone | IC50 | 4.3 [1], 5.4 [2], 29.0 [3] |
 | [(3S)-3-[[4-Hydroxy-4-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexyl]amino]pyrrolidin-1-yl]-[1-[6-(trifluoromethyl)pyridin-2-yl]piperidin-4-yl]methanone | IC50 | 4.5 [1], 8.8 [2], 88.0 [3] |
 | [(3S)-3-[[4-Hydroxy-4-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexyl]amino]pyrrolidin-1-yl]-[1-[3-(trifluoromethyl)phenyl]piperidin-4-yl]methanone | IC50 | 3.6 [1], 6.1 [2], 37.0 [3] |
 | [(3S)-3-[[4-Hydroxy-4-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexyl]amino]pyrrolidin-1-yl]-[1-[4-(trifluoromethyl)pyridin-2-yl]piperidin-4-yl]methanone | IC50 | 1.9 [1], 3.3 [2], 12.0 [3] |
 | N-[2-[(3S)-3-[[4-Hydroxy-4-[5-(1,3-thiazol-2-yl)pyridin-2-yl]cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 1.8 [1], 6.0 [2], 67.0 [3] |
 | N-[2-[(3S)-3-[[4-Hydroxy-4-(5-pyrazin-2-ylpyridin-2-yl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 3.8 [1], 6.0 [2], 6.5 [3] |
 | Unii-2bod5iud08 | IC50 | 20.0 [1], 100.0 [2] |
 | N-(3,4-Dichlorophenyl)-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide | IC50 | 170.0 [1], 965.0 [2] |
| N-(3,4-Dichlorophenyl)-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide | Ki | 400.0 [1] |
 | 3,4-Dichloro-N-[5-chloro-2-[(5-cyclopropyltetrazol-1-yl)methyl]phenyl]benzenesulfonamide | Ki | 31.62 [1], 100.0 [2] |
 | 2-(Methylcarbamoylamino)-N-[2-[[4-[(4-methylsulfanylphenyl)methylamino]-1-propylpiperidin-3-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 3.0 [1], 3.8 [2], 8.0 [3] |
 | N-[2-[[4-(Dimethylamino)-2-[(4-methylphenyl)methylamino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 5.5 [1], 9.9 [2], 12.6 [3] |
 | 2-Amino-N-[2-[[4-[(4-methylsulfanylphenyl)methylamino]-1-propylpiperidin-3-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 2.0 [1], 3.4 [2], 5.4 [3] |
 | 2-Amino-N-[2-[[1-methyl-4-[(4-methylsulfanylbenzoyl)amino]piperidin-3-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 1.8 [1], 2.0 [2], 38.5 [3] |
 | N-[2-[[4-(Dimethylamino)-2-[(4-methylsulfanylphenyl)methylamino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 2.4 [1], 6.0 [2], 22.5 [3] |
 | 2-Amino-N-[2-[[1-butyl-4-[(4-methylsulfanylphenyl)methylamino]piperidin-3-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 7.9 [1], 13.0 [2], 19.0 [3] |
 | N-[2-[[4-(Dimethylamino)-2-[(4-methoxyphenyl)methylamino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 8.0 [1], 12.5 [2], 41.4 [3] |
 | 3-Amino-N-[2-[[4-[(4-methylsulfanylphenyl)methylamino]-1-propylpiperidin-3-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 3.0 [1], 6.1 [2], 26.0 [3] |
 | 2-Amino-N-[2-[[1-methyl-4-[(4-methylsulfanylphenyl)methylamino]piperidin-3-yl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide | IC50 | 0.95 [1], 5.0 [2], 27.5 [3] |
 | N-[2-[[2-[[4-[(4-Methylsulfanylphenyl)methylamino]-1-propylpiperidin-3-yl]amino]-2-oxoethyl]carbamoyl]-4-(trifluoromethyl)phenyl]pyrrolidine-1-carboxamide | IC50 | 4.8 [1], 8.7 [2], 21.0 [3] |
 | N-[2-[[(1S,2R)-2-[(4-Chlorophenyl)methylamino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 268.0 [1], 790.0 [2], 2117.2 [3] |
 | 2,4-Dimethyl-N-[(1R,2S)-2-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]cyclohexyl]benzamide | IC50 | 4130.0 [1], 7847.0 [2] |
 | N-[2-[[(1S,2R)-2-[(4-Iodobenzoyl)amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | IC50 | 30.0 [1], 37.0 [2], 160.0 [3] |
Calculator
